A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Active, not recruiting · NCT06624085 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 1 | 2026-10-06 | NCT06624085 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hoffmann-La Roche | 280 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AdventHealth Cancer Institute | Orlando | United States | 11 |
| Auxilio Mutuo Cancer Center | San Juan | Puerto Rico | 7 |
| Baylor College of Medicine | Houston | United States | 306 |
| Kansas City VA Medical Center | Kansas City | United States | 1 |
| Renovatio Clinical | The Woodlands | United States | 20 |
| Stony Brook Univ Cancer Ctr | Stony Brook | United States | 3 |
| Thomas Jefferson University | Philadelphia | United States | 165 |
| University of California Los Angeles (UCLA) - Cancer Care - Santa Monica | Santa Monica | United States | 2 |
| University of Illinois Cancer Center | Chicago | United States | 34 |